Response to Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561–2569

26 april 2023
door American Diabetes Association - Care

National Heart, Lung, and Blood Institute10.13039/100000050U01HL4164275N92019D0002775N92019D0002875N92019D0002975N92019D00030R01HL090863R01HL109282R01HL109284R01HL109301R01HL109315R01HL109319U01HL41652U01HL41654U01HL65520U01HL65521National Institute of Environmental Health Sciences10.13039/100000066P30ES009089P42ES033719R01ES021367R01ES025216R01ES032638

Bekijk het originele bericht

Response to Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561–2569

Wellicht vindt u dit ook interessant

Meld u aan voor de maandelijkse nieuwsbrief

Categorieën

Patiëntvoorbeelden m.b.t. vergoeding

Voeg je koptekst hier toe

Vergoeding diabetesmiddelen